Here are four things to know:
1. The GI sealant is designed to minimize staple-line leakage in gastrointestinal resection procedures.
2. The FDA trial will be a multi-center, multinational, randomized, double-arm, single-blind study.
3. There will be study sites in both the Unites States and Europe.
4. The LifeSeal Surgical Sealant Kit has received the CE Mark.
More articles on GI/endoscopy:
Surveillance endoscopy improves esophageal cancer outcomes in Barrett’s esophagus patients: 3 insights
Small bowel resection inpatient costs total $28.5k & 7 more statistics
Dr. Maxime Mahe wins 2016 AGA-Athena Troxel Blackburn Award: 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.